20150717

The 13th New Pharmaceutical Technology and Engineering Conference Program
SHINAGAWA Intercity Hall, TOKYO, JAPAN
Organized by: The New Pharmaceutical Technology and Engineering Institute (NPTE)
Wed. July 22, 2015

Thurs. July 23, 2015

-10:0010:10

Opening Remarks

1

9:5010:40

Masafumi Nogimori
Representative Director, Chairman of the Board, Astellas Pharma Inc.
"Global Strategy of Astellas Pharma"1

10:1011:00

Mami Yabuki
Principal Inspector, Office of Manufacturing/Quality and CompliancePharmaceuticals and Medical Devices Agency(PMDA), Japan"Trends on PIC/S and Good Manufacturing Practices (GMP) Activities"

210:4011:30

Stephen T. Buckley, Ph.D.
Team Leader, Discovery ADME, Novo Nordisk A/S"Therapeutic Delivery of Peptides and Proteins: Examining the Challenges andOpportunities"2

11:0011:50

3

11:3012:20

3

12:5013:40

4

13:1014:00

4

13:4014:30

14:5015:05

Jingtao Zhang, Ph.D.
Principal Scientist, Department of Pharmaceutical Sciences, Department of RNA
Therapeutics, Merck Research Laboratories, Merck & Co., Inc.
" Multi-dimensional Characterization of siRNA Delivery Nanoparticles"
Lunch Time （60 min.）Rohit Ramachandran, Ph.D.
Assistant Professor, Chemical and Biochemical EngineeringRutgers, The State University of New Jersey"A Novel Continuous Tablet Manufacturing Process Integrated with inline PAT andAutomated Control System"
Lian RyanOperations Lead, Pfizer Ireland Pharmaceuticals"Managing Solid Dose Pharmaceutical Operations in an Advanced Containment
Technology Facility"

15:0515:55

6

15:5516:45

17:1519:15

Steve Hammond, Ph.D.
Senior Director, Process Analytical Sciences Group, Pfizer Global Supply, Pfizer"Portable Continuous Miniature and Modular Manufacturing Engineering and Control
Strategy"
Yoshiteru Takahashi, Ph.D.
Executive Corporate Officer, Deputy Vice President of Manufacturing Division, GeneralManager of Pharmaceutical Technology Center, SAWAI Pharmaceutical Co., Ltd.
"Development of High Value-added Generic Drugs: Establishment of Laser Printing
Technology on Plain Tablets and Development of Cilostazol Orally DisintegratingTablet"
Coffee Break (20 min.)5

14:0014:50

6

15:1016:00

Antonios Zavaliangos, Ph.D.
A.W. Grosvenor Professor, Materials Science and Engineering, Drexel University"Mechanistic Understanding of Failure in Bilayer Tablets"

Yasushi MimaManager, Asia Pacific Quality Assurance Global IMP GMP Quality Assurance Department,CMC Center, Takeda Pharmaceutical Company Limited"Takeda's Approach to Quality Knowledge Transfer"716:0016:50

Masafumi Dohi
Research Fellow, Oral Formulation Technology, Pharmaceutical Research & TechnologyLabs., Astellas Pharma Inc.
"Contribution to Stable Production –Pharmaceutical Development with QbD Concept& High Quality Assurance applying PAT"

Break (30 min.)-16:5017:00

Closing Remarks

Coffee Break (20 min.)
The New Pharmaceutical Technology and Engineering Foundation
Particle Design & Financial Aid Awards Ceremony 2015
Particle Design Award 2015 Commemorative Lecture

5

Yoshito Ohnishi, Ph.D.
Assistant Director, Formulation Research Lab., Taiho Pharmaceutical Co., Ltd.
"Development Concept of Orally Disintegrating Anti-cancer Drug and itsPharmaceutical Technology"
Lunch Time （50 min.）

Wataru Momose, Ph.D.
Senior Researcher, Technology/Oral Formulation Technology, Pharmaceutical Research
and Technology Labs., Astellas Pharma Inc.
"Effective Use of PAT in New Drug Development and Reform and Prospect of Drug
Manufacturing"

NETWORKING PARTY*Simultaneous Interpretation will be available, except luncheon seminars